| Betoptic-S (U.S.N.L.M.) | |
|---|---|
| Dosing | 1 drop bid (q12hr) |
| Chem Specs | betaxolol 0.25% |
| Quantities | 2.5, 5, 10, 15ml |
| Cost | 392.00/10ml |
| Class | Beta 1 (cardioselective) Beta-Blocker |
| Action | Reduces aqueous humor production. |
| Usage | Indicated for elevated IOP of chronic open-angle glaucoma or ocular hypertension. |
| Evaluate blood pressure, pulse, neurological and respiratory status before and during treatment. Evaluate blood pressure, pulse, neurological and respiratory status before and during treatment. |
|
| Contraindications | Sinus bradycardia, greater than a first degree atrioventricular block,
cardiogenic shock, overt cardiac failure, hypersensitivity to any component of the medication. Sinus bradycardia, greater than a first degree atrioventricular block, cardiogenic shock, overt cardiac failure, hypersensitivity to any component of the medication. |
| Pediatric use | Safety and IOP-lowering effect has been demonstrated in pediatric patients |
| Pregnancy | Category C. Postimplantation loss demonstrated in rabbits and rats. |
| "S" = Suspension. Resin suspension formulation intended to extend residence time. More comfortable than but equipotent with Betoptic 0.5% solution. 0.01% BAK preserved. "S" = Suspension. Resin suspension formulation intended to extend residence time. More comfortable than but equipotent with Betoptic 0.5% solution. 0.01% BAK preserved. |